The recruitment of MoMFs actively participates in NAFLD/NASH progression, and is largely dependent on an array of chemokine receptors (e.g., CCR2, CCR5, CXCR3). The gene discussed is CCR2; the disease is metabolic dysfunction-associated steatohepatitis.